Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimal Stent Duration After Ureteroscopy

NCT: NCT06045962 · ACTIVE_NOT_RECRUITING

NCT IDNCT06045962
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-01
Completion2026-09-01

Brief Summary

The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.

Frequently Asked Questions

What is Optimal Stent Duration After Ureteroscopy?

Optimal Stent Duration After Ureteroscopy is a clinical trial registered under NCT06045962. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06045962?

The current status of NCT06045962 (Optimal Stent Duration After Ureteroscopy) is: ACTIVE_NOT_RECRUITING.

When did Optimal Stent Duration After Ureteroscopy start?

Optimal Stent Duration After Ureteroscopy started on 2023-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑